Barnes-Jewish Hospital | Washington University Physicians
SITEMAN CANCER CENTER AT 20: A RETROSPECTIVE

SITEMAN CANCER CENTER AT 20: A RETROSPECTIVE

BY PAM MCGRATH
IMAGES COURTESY OF WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND SITEMAN CANCER CENTER

When Barnes-Jewish Hospital and Washington University School of Medicine established the Alvin J. Siteman Cancer Center in 1999, the partnering institutions already shared a decades-long history of advancing cancer research and treatment.

Read More
THE BRAIN GEEKS

THE BRAIN GEEKS

BY PAM MCGRATH
PHOTOS BY JAY FRAM

Eric Leuthardt, MD, and Albert Kim, MD, PhD, frequently engage in long talks together about the brain and the yet-to-be-solved mysteries of this complicated organ. Because both men are Washington University neurosurgeons treating patients at Barnes-Jewish Hospital and Siteman Cancer Center, it could be assumed these conversations are a natural consequence of their mutual profession.

Read More
TREATING ADDICTION: PREGNANCY AND OPIOIDS

TREATING ADDICTION: PREGNANCY AND OPIOIDS

BY JEN MILLER
PHOTOS BY JAY FRAM

When Jeannie Kelly, MD, MS, a Washington University maternal-fetal medicine specialist at Barnes-Jewish Hospital, first arrived on the medical campus in St. Louis in 2016, she had already seen how opioid use can devastate a community. “I finished my training in Boston, where the opioid epidemic was exploding,” she says. While working there, Kelly saw addiction and overdoses. She was aware of the difficulties and dangers for pregnant women addicted to opioids, and the great risks to their babies. And she wanted to help.

Read More
ONCOLOGY REPORT: LOWERING THE RISKS OF TREATMENT SIDE EFFECTS

ONCOLOGY REPORT: LOWERING THE RISKS OF TREATMENT SIDE EFFECTS

BY JULIA EVANGELOU STRAIT

The current age of cancer care employs surgery, chemotherapy and radiation, in combination or alone, to eradicate tumors and offer the potential for remission. But the side effects of some of these therapies can introduce new complications requiring additional treatment. Oncologists and their patients work in tandem to fight the disease in ways that preserve life and protect health with as little risk as possible.

Read More
POTENTIAL NEW THERAPY FOR CROHN’S, COLITIS IDENTIFIED

POTENTIAL NEW THERAPY FOR CROHN’S, COLITIS IDENTIFIED

BY TAMARA BHANDARI

More than 1 million people in the United States have inflammatory bowel disease, or IBD. This condition, which includes Crohn’s disease and ulcerative colitis, causes miserable episodes of abdominal pain, diarrhea and in severe cases, rectal bleeding, making life for those afflicted with the disease especially difficult.

Read More
First2223242527293031Last

What is Trending: